Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Medtronic
Fuji
Citi
Moodys
Daiichi Sankyo
Colorcon
Dow
US Department of Justice

Generated: May 22, 2018

DrugPatentWatch Database Preview

Ajanta Pharma Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?

AJANTA PHARMA LTD has twenty-two approved drugs.

There is one tentative approval on AJANTA PHARMA LTD drugs.

Summary for Ajanta Pharma Ltd
US Patents:0
Tradenames:18
Ingredients:18
NDAs:22
Drug Master File Entries: 2

Drugs and US Patents for Ajanta Pharma Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 205545-001 Jul 27, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Ajanta Pharma Ltd RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 207797-002 Sep 28, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Ajanta Pharma Ltd LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 203957-002 Oct 14, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Ajanta Pharma Ltd MONTELUKAST SODIUM montelukast sodium GRANULE;ORAL 203438-001 Jul 31, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Chubb
Julphar
Healthtrust
Johnson and Johnson
Argus Health
Federal Trade Commission
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.